| Dataset | Agency | Advertised | Days since update | Over budget |
| COVID-19 Vaccinations in the United States,County |
| daily | 1265 |
1265.4x |
| COVID-19 Vaccinations in the United States,Jurisdiction |
| daily | 1265 |
1265.4x |
| COVID-19 Vaccination Demographics in the United States,National |
| daily | 1265 |
1265.4x |
| COVID-19 Vaccination Trends in the United States,National and Jurisdictional |
| daily | 1265 |
1265.4x |
| COVID-19 Vaccination Age and Sex Trends in the United States, National and Jurisdictional |
| daily | 1265 |
1265.4x |
| COVID-19 Primary Series Completion, Booster Dose Eligibility, and Booster Dose Receipt by Age, United States |
| daily | 1265 |
1265.4x |
| COVID-19 Booster Dose Eligibility in the United States |
| daily | 1265 |
1265.4x |
| COVID-19 Vaccines Up to Date Status |
| daily | 1111 |
1110.7x |
| COVID-19 Updated Vaccines Distributed |
| daily | 1110 |
1110.3x |
| Claims Reimbursement to Health Care Providers and Facilities for Testing, Treatment, and Vaccine Administration of the Uninsured |
| weekly | 1700 |
242.8x |
| Cumulative Influenza Vaccination Coverage, Adults 18 years and older, by Age Group and Race/Ethnicity, United States |
| weekly | 1671 |
238.7x |
| Obesity among children and adolescents aged 2–19 years, by selected characteristics: United States |
| weekly | 1644 |
234.8x |
| Cumulative Influenza Vaccination Coverage and Intent for Vaccination Among Adults 18 Years and Older by Age, Race/Ethnicity, and COVID-19 Vaccination and Intent, United States; IPSOS Knowledge Panel and NORC AmeriSpeak Omnibus Surveys. |
| weekly | 1307 |
186.7x |
| Weekly Cumulative Estimated Number of Influenza Vaccinations Administered in Pharmacies and Physician Medical Offices, Adults 18 years and older, United States |
| weekly | 887 |
126.7x |
| Weekly Cumulative Influenza Vaccination Coverage, Children 6 months through 17 years, United States |
| weekly | 887 |
126.7x |
| Cumulative Influenza Vaccination Coverage Differences by Race/Ethnicity, Children 6 months through 17 years, United States |
| weekly | 887 |
126.7x |
| Mental Health Care in the Last 4 Weeks |
| every 2 weeks | 1430 |
102.1x |
| Telemedicine Use in the Last 4 Weeks |
| every 2 weeks | 1430 |
102.1x |
| Nationwide Commercial Laboratory Seroprevalence Survey |
| biweekly | 1371 |
97.9x |
| HHS Provider Relief Fund |
| weekly | 579 |
82.8x |
| COVID-19 Coverage Assistance Fund: Claims Reimbursement to Health Care Providers and Facilities for Services to the Underinsured |
| weekly | 579 |
82.8x |
| Weekly Cumulative Influenza Vaccination Coverage, by Flu Season and Race/Ethnicity, Medicare Fee-For-Service Beneficiaries aged ≥65 years, United States |
| weekly | 555 |
79.2x |
| Monthly Counts of Deaths by Select Causes, 2014-2019 |
| monthly | 2093 |
67.5x |
| Vaccine Hesitancy for COVID-19: County and local estimates |
| monthly | 1959 |
63.2x |
| Vaccine Hesitancy for COVID-19: Public Use Microdata Areas (PUMAs) |
| monthly | 1959 |
63.2x |
| Provider Relief Fund COVID-19 Nursing Home Quality Incentive Program |
| monthly | 1913 |
61.7x |
| Indicators of Anxiety or Depression Based on Reported Frequency of Symptoms During Last 7 Days |
| every 2 weeks | 754 |
53.9x |
| Indicators of Health Insurance Coverage at the Time of Interview |
| every 2 weeks | 754 |
53.9x |
| Weekly Differences in Cumulative RSV Vaccination Coverage Among Adults 75 and Older and 60-74 Years with High-Risk Conditions Ever Vaccinated with RSV Vaccine, Overall, by Selected Demographics |
| weekly | 322 |
46x |
| Rates of COVID-19 Cases or Deaths by Age Group and Vaccination Status |
| monthly | 1344 |
43.3x |
| Rates of COVID-19 Cases or Deaths by Age Group and Vaccination Status and Booster Dose |
| monthly | 1344 |
43.3x |
| Rates of COVID-19 Cases or Deaths by Age Group and Vaccination Status and Second Booster Dose |
| monthly | 1344 |
43.3x |
| COVID-19 Case Surveillance Public Use Data |
| monthly | 841 |
27.1x |
| COVID-19 Case Surveillance Public Use Data with Geography |
| monthly | 841 |
27.1x |
| Lack of Social Connection |
| monthly | 754 |
24.3x |
| Weekly Cumulative Estimated Number of RSV Vaccinations Administered in Retail Pharmacies and Physicians' Medical Offices, Adults 50 to 74 Years and 75 years and older, United States |
| weekly | 161 |
23x |
| CDC.gov CleanSlate and Relaunch URL Mappings |
| monthly | 678 |
21.9x |
| Preliminary U.S. RSV Burden Estimates |
| weekly | 110 |
15.7x |
| Preliminary Estimates of Cumulative RSV Hospitalizations by Week |
| weekly | 110 |
15.7x |
| COVID-19 Hospital Data from the National Hospital Care Survey |
| every 2 months | 821 |
13.2x |
| Weekly Cumulative Doses (in Millions) of Influenza Vaccine Distributed by Flu Season in the United States |
| weekly | 86 |
12.3x |
| NWSS Public SARS-CoV-2 Wastewater Metric Data |
| weekly | 82 |
11.7x |
| NWSS Public SARS-CoV-2 Concentration in Wastewater Data |
| weekly | 82 |
11.7x |
| Weekly Respiratory Pathogens and Vaccination (RPV) Metrics for Nursing Home Residents by Jurisdiction, National Healthcare Safety Network (NHSN) |
| weekly | 65 |
9.3x |
| VSRR - State and National Provisional Counts for Live Births, Deaths, and Infant Deaths |
| quarterly | 686 |
7.5x |
| Botulism |
| annual | 2715 |
7.4x |
| Weekly Respiratory Virus Vaccination Data, Children 6 Months-17 Years and Adults 18 Years and Older, National Immunization Survey |
| weekly | 44 |
6.2x |
| Provisional COVID-19 death counts, rates, and percent of total deaths, by jurisdiction of residence |
| weekly | 41 |
5.8x |
| Provisional COVID-19 death counts and rates by month, jurisdiction of residence, and demographic characteristics |
| weekly | 41 |
5.8x |
| Death rates for suicide, by sex, race, Hispanic origin, and age: United States |
| annually | 1969 |
5.4x |
| NHIS Interactive Quarterly Early Release Estimates |
| quarterly | 492 |
5.3x |
| Monthly Cumulative Number and Percent of Adults 75 Years and Older Who Received 1+ RSV Vaccination Doses by Jurisdiction, United States |
| monthly | 161 |
5.2x |
| Monthly Cumulative Number and Percent of Children <8 Months Who Received 1+ Monoclonal Antibody Doses by Jurisdiction, United States |
| monthly | 161 |
5.2x |
| Health conditions among children under age 18, by selected characteristics: United States |
| annually | 1834 |
5x |
| Normal weight, overweight, and obesity among adults aged 20 and over, by selected characteristics: United States |
| annually | 1644 |
4.5x |
| Drug overdose death rates, by drug type, sex, age, race, and Hispanic origin: United States |
| annually | 1644 |
4.5x |
| Delay or nonreceipt of needed medical care, prescription drugs, or dental care during the past 12 months due to cost: United States |
| annually | 1644 |
4.5x |
| Initial injury-related visits to hospital emergency departments, by sex, age, and intent and mechanism of injury: United States |
| annually | 1644 |
4.5x |
| Medicaid coverage among persons under age 65, by selected characteristics: United States |
| annually | 1644 |
4.5x |
| Respiratory Syncytial Virus Laboratory Data (NREVSS) |
| annually | 1468 |
4x |
| Preliminary Estimates of Visits to Health Centers in the United States, January 2022-December 2025 |
| monthly | 120 |
3.9x |
| NHANES Select Chronic Conditions Prevalence Estimates |
| annually | 1339 |
3.7x |
| NHANES Select Mean Dietary Intake Estimates |
| annually | 1339 |
3.7x |
| NHANES Select Oral Health Prevalence Estimates |
| annually | 1339 |
3.7x |
| NHANES Select Infectious Diseases Prevalence Estimates |
| annually | 1339 |
3.7x |
| autism prevalence studies |
| annually | 1275 |
3.5x |
These datasets carry a recurring cadence label but their own titles state a
closed coverage period, and their data stops where their titles say it stops. The data is not
abandoned — the cadence label on it is simply wrong. Listed separately and excluded from the
count above.